{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:07:57Z","timestamp":1772946477253,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011010","name":"European SocieTy for Radiotherapy and Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013405","name":"Rijksdienst voor Ondernemend Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["13217"],"award-info":[{"award-number":["13217"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.prro.2025.07.006","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:22:43Z","timestamp":1755825763000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver Metastases Treated With Magnetic Resonance Imaging Guided Stereotactic Body Radiation Therapy: Outcomes of Tolerability, Acute Toxicity, and Quality of Life From the MOMENTUM Study"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-4251","authenticated-orcid":false,"given":"Julia E.","family":"Peltenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalyne","family":"Westley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois A.","family":"Daamen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Tissier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uffe","family":"Bernchou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Boeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra M.","family":"Braam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn P.W.","family":"Intven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Jakob","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Michael W.","family":"Straza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies E.","family":"Nowee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.07.006_bib0001","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12094-019-02182-z","article-title":"Multidisciplinary management of liver metastases in patients with colorectal cancer: A consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM","volume":"22","author":"Vera","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/cncr.24081","article-title":"Survival after hepatic resection of colorectal cancer metastases: A national experience","volume":"115","author":"Robertson","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2025.07.006_bib0003","first-page":"e935","article-title":"Stereotactic body radiotherapy for inoperable liver tumors: Results of a single institutional experience","volume":"8","author":"Hijazi","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.prro.2025.07.006_bib0004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1186\/1471-2407-14-810","article-title":"Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma","volume":"14","author":"Hackl","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2025.07.006_bib0005","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0006","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/jgh.15011","article-title":"Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma","volume":"35","author":"Park","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.prro.2025.07.006_bib0007","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study","volume":"45","author":"M\u00e9ndez Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijrobp.2008.01.005","article-title":"Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography","volume":"71","author":"Guckenberger","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.07.006_bib0009","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: A review of evidence","volume":"82","author":"H\u00f8yer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.07.006_bib0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.10100729","article-title":"Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment","volume":"257","author":"Niekel","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2025.07.006_bib0011","article-title":"Interobserver variation in tumor delineation of liver metastases using magnetic resonance imaging","volume":"30","author":"Peltenburg","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/SLA.0000000000002353","article-title":"Laparoscopic versus open resection for colorectal liver metastases: The OSLO-COMET randomized controlled trial","volume":"267","author":"Fretland","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2025.07.006_bib0013","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.3390\/cancers15174346","article-title":"Efficacy of thermal ablation for small-size (0-3 cm) versus intermediate-size (3-5 cm) colorectal liver metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)","volume":"15","author":"Dijkstra","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2025.07.006_bib0014","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejso.2022.09.006","article-title":"Ablation versus resection for resectable colorectal liver metastases - Health care related cost and survival analyses from a quasi-randomised study","volume":"49","author":"Tinguely","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0015","first-page":"45","article-title":"High versus low dose Stereotactic body radiation therapy for hepatic metastases","volume":"20","author":"Kok","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110090","article-title":"MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters","volume":"192","author":"van Overeem Felter","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2022.04.005","article-title":"First multicentre experience of SABR for lymph node and liver oligometastatic disease on the Unity MR-Linac","volume":"22","author":"Janssen","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0018","article-title":"Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases","volume":"12","author":"Uder","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3857\/roj.2020.00976","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: Initial clinical experience","volume":"39","author":"Ugurluer","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2025.07.006_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.610637","article-title":"Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: Initial clinical experience and patient-reported outcomes","volume":"11","author":"Weykamp","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0021","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2021.06.005","article-title":"Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial","volume":"170","author":"van Dams","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0023","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fonc.2020.01328","article-title":"The MOMENTUM Study: An international registry for the evidence-based introduction of MR-guided adaptive therapy","volume":"10","author":"de Mol van Otterloo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0024","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semradonc.2014.02.009","article-title":"The magnetic resonance imaging-linac system","volume":"24","author":"Lagendijk","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: A review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110235","article-title":"Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study","volume":"195","author":"Christ","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0027","series-title":"Common terminology criteria for adverse events (CTCAE)","year":"2010"},{"key":"10.1016\/j.prro.2025.07.006_bib0028","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2025.07.006_bib0029","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.prro.2025.07.006_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2022.01.009","article-title":"Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac","volume":"167","author":"van de Lindt","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0031","article-title":"Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac","volume":"15","author":"Hall","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.prro.2025.07.006_bib0032","first-page":"55","article-title":"Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance","volume":"26","author":"Gani","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0033","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1002\/mp.13826","article-title":"Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans","volume":"46","author":"van den Wollenberg","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2025.07.006_bib0034","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2025.07.006_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2025.07.006_bib0036","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2020.11.045","article-title":"The Dutch-Belgian Registry of stereotactic body radiation therapy for liver metastases: Clinical outcomes of 515 patients and 668 metastases","volume":"109","author":"M\u00e9ndez Romero","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.07.006_bib0037","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","article-title":"Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors","volume":"70","author":"M\u00e9ndez Romero","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.07.006_bib0038","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13014-017-0818-8","article-title":"Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer","volume":"12","author":"Mutsaers","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0039","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","article-title":"A multi-institutional experience of MR-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2025.07.006_bib0040","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1002\/cam4.4139","article-title":"Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis","volume":"10","author":"Yoon","year":"2021","journal-title":"Cancer Med"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:47:52Z","timestamp":1772894872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1879850025002127"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.07.006","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Metastases Treated With Magnetic Resonance Imaging Guided Stereotactic Body Radiation Therapy: Outcomes of Tolerability, Acute Toxicity, and Quality of Life From the MOMENTUM Study","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}